Explore
Validate
LearnV3012
antibody from NSJ Bioreagents
Targeting: CD44
CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
Western blot
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [15]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V3012 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- CD44 Antibody
- Antibody type
- Monoclonal
- Antigen
- Purified CD44 antigen (PGp-1) from lymphocyte membrane was used as the immunogen for the CD44 antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- DF1485
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the CD44 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features.
Modulation of CD44 Activity by A6-Peptide.
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
CD44-expressing undifferentiated carcinoma with rhabdoid features of the pancreas: molecular analysis of aggressive invasion and metastasis.
Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.
Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.
Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.
Staphylococcus aureus Infection in Humanized Mice: A New Model to Study Pathogenicity Associated With Human Immune Response.
Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
Guo W, Wang W, Zhu Y, Zhu X, Shi Z, Wang Y
International journal of clinical and experimental pathology 2015;8(7):8008-17
International journal of clinical and experimental pathology 2015;8(7):8008-17
Modulation of CD44 Activity by A6-Peptide.
Finlayson M
Frontiers in immunology 2015;6:135
Frontiers in immunology 2015;6:135
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q, Yang Y, Wu S, Li W, Zhang N, Dong X, Ou Y
Diagnostic pathology 2015 Sep 25;10:176
Diagnostic pathology 2015 Sep 25;10:176
ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
Jang BG, Lee HE, Kim WH
Virchows Archiv : an international journal of pathology 2015 Oct;467(4):393-403
Virchows Archiv : an international journal of pathology 2015 Oct;467(4):393-403
The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome.
Masarwah A, Tammi M, Sudah M, Sutela A, Oikari S, Kosma VM, Tammi R, Vanninen R, Auvinen P
Breast cancer research and treatment 2015 Oct;153(3):625-34
Breast cancer research and treatment 2015 Oct;153(3):625-34
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Salinas Tejedor L, Berner G, Jacobsen K, Gudi V, Jungwirth N, Hansmann F, Gingele S, Prajeeth CK, Baumgärtner W, Hoffmann A, Skripuletz T, Stangel M
Brain, behavior, and immunity 2015 Nov;50:155-65
Brain, behavior, and immunity 2015 Nov;50:155-65
CD44-expressing undifferentiated carcinoma with rhabdoid features of the pancreas: molecular analysis of aggressive invasion and metastasis.
Ohmoto T, Yoshitani N, Nishitsuji K, Takayama T, Yanagisawa Y, Takeya M, Sakashita N
Pathology international 2015 May;65(5):264-70
Pathology international 2015 May;65(5):264-70
Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee D, Na J, Ryu J, Kim HJ, Nam SH, Kang M, Jung JW, Lee MS, Song HE, Choi J, Lee GH, Kim TY, Chung JK, Park KH, Kim SH, Kim H, Seo H, Kim P, Youn H, Lee JW
Hepatology (Baltimore, Md.) 2015 Jun;61(6):1978-97
Hepatology (Baltimore, Md.) 2015 Jun;61(6):1978-97
Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.
Hong I, Hong SW, Chang YG, Lee WY, Lee B, Kang YK, Kim YS, Paik IW, Lee H
Annals of coloproctology 2015 Jun;31(3):84-91
Annals of coloproctology 2015 Jun;31(3):84-91
Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA, Kowalski LP
Clinical & experimental metastasis 2015 Jan;32(1):55-63
Clinical & experimental metastasis 2015 Jan;32(1):55-63
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.
Bonneau C, Rouzier R, Geyl C, Cortez A, Castela M, Lis R, Daraï E, Touboul C
Gynecologic oncology 2015 Jan;136(1):112-20
Gynecologic oncology 2015 Jan;136(1):112-20
Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
Oon ML, Thike AA, Tan SY, Tan PH
Breast cancer research and treatment 2015 Feb;150(1):31-41
Breast cancer research and treatment 2015 Feb;150(1):31-41
A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.
Tertipis N, Hammar U, Näsman A, Vlastos A, Nordfors C, Grün N, Ährlund-Richter A, Sivars L, Haeggblom L, Marklund L, Hammarstedt-Nordenvall L, Chaturvedi AK, Munck-Wikland E, Ramqvist T, Bottai M, Dalianis T
European journal of cancer (Oxford, England : 1990) 2015 Aug;51(12):1580-7
European journal of cancer (Oxford, England : 1990) 2015 Aug;51(12):1580-7
Staphylococcus aureus Infection in Humanized Mice: A New Model to Study Pathogenicity Associated With Human Immune Response.
Knop J, Hanses F, Leist T, Archin NM, Buchholz S, Gläsner J, Gessner A, Wege AK
The Journal of infectious diseases 2015 Aug 1;212(3):435-44
The Journal of infectious diseases 2015 Aug 1;212(3):435-44
Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
Mikami S, Mizuno R, Kosaka T, Saya H, Oya M, Okada Y
International journal of cancer 2015 Apr 1;136(7):1504-14
International journal of cancer 2015 Apr 1;136(7):1504-14
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- Western blot testing of human U937 cells with CD44 antibody (clone DF1485). Predicted molecular weight: 80-95kDa.
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- Immunofluorescence staining of human HeLa cells with CD44 antibody (green, clone DF1485) and Reddot nuclear stain (red).
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human breast carcinoma stained with CD44 antibody (DF1485)
